Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Hanson

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|December 7, 2023
Development of Ligands for the Super Conserved Orphan G Protein-Coupled Receptor GPR27 with Improved Efficacy and PotencyThanigaimalai Pillaiyar, Monika Wozniak, Dayana Abboud, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2004
Effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in a porcine model of acute pulmonary embolismAlexandre Ghuysen, Bernard Lambermont, Jean-Michel Dogné, et al.
Prostaglandins & Other Lipid Mediators|November 24, 2005
Effects of BM-573, a thromboxane A2 modulator on systemic hemodynamics perturbations induced by U-46619 in the pigVincent Tchana-Sato, Jean-Michel Dogné, Bernard Lambermont, et al.
Frontiers in Immunology|June 20, 2022
The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-BGiulia D'Uonnolo, Nathan Reynders, Max Meyrath, et al.
Experimental Aging Research|January 13, 2024
Music-Evoked Autobiographical Memories are Associated with Negative Affect in Younger and Older AdultsKendra Mehl, Alaine E Reschke-Hernandez, Julien Hanson, et al.
Cells|June 21, 2019
The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor MicroenvironmentNathan Reynders, Dayana Abboud, Alessandra Baragli, et al.
Current Drug Targets|December 30, 2017
Therapeutic Applications of Prostaglandins and Thromboxane A2 Inhibitors in Abdominal Aortic AneurysmsAudrey Courtois, Georgios Makrygiannis, Jean-Paul Cheramy-Bien, et al.
Nature Communications|September 22, 2020
GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G<sub>s</sub> and G<sub>q/11</sub>Dayana Abboud, Adrian F Daly, Nadine Dupuis, et al.
Current Medicinal Chemistry|May 12, 2004
New developments on thromboxane and prostacyclin modulators part I: thromboxane modulatorsJean-Michel Dogné, Xavier de Leval, Julien Hanson, et al.
Journal of Medicinal Chemistry|May 19, 2018
Enhancing Action of Positive Allosteric Modulators through the Design of Dimeric CompoundsThomas Drapier, Pierre Geubelle, Charlotte Bouckaert, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|December 7, 2023
Development of Ligands for the Super Conserved Orphan G Protein-Coupled Receptor GPR27 with Improved Efficacy and PotencyThanigaimalai Pillaiyar, Monika Wozniak, Dayana Abboud, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2004
Effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in a porcine model of acute pulmonary embolismAlexandre Ghuysen, Bernard Lambermont, Jean-Michel Dogné, et al.
Prostaglandins & Other Lipid Mediators|November 24, 2005
Effects of BM-573, a thromboxane A2 modulator on systemic hemodynamics perturbations induced by U-46619 in the pigVincent Tchana-Sato, Jean-Michel Dogné, Bernard Lambermont, et al.
Frontiers in Immunology|June 20, 2022
The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-BGiulia D'Uonnolo, Nathan Reynders, Max Meyrath, et al.
Experimental Aging Research|January 13, 2024
Music-Evoked Autobiographical Memories are Associated with Negative Affect in Younger and Older AdultsKendra Mehl, Alaine E Reschke-Hernandez, Julien Hanson, et al.
Cells|June 21, 2019
The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor MicroenvironmentNathan Reynders, Dayana Abboud, Alessandra Baragli, et al.
Current Drug Targets|December 30, 2017
Therapeutic Applications of Prostaglandins and Thromboxane A2 Inhibitors in Abdominal Aortic AneurysmsAudrey Courtois, Georgios Makrygiannis, Jean-Paul Cheramy-Bien, et al.
Nature Communications|September 22, 2020
GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G<sub>s</sub> and G<sub>q/11</sub>Dayana Abboud, Adrian F Daly, Nadine Dupuis, et al.
Current Medicinal Chemistry|May 12, 2004
New developments on thromboxane and prostacyclin modulators part I: thromboxane modulatorsJean-Michel Dogné, Xavier de Leval, Julien Hanson, et al.
Journal of Medicinal Chemistry|May 19, 2018
Enhancing Action of Positive Allosteric Modulators through the Design of Dimeric CompoundsThomas Drapier, Pierre Geubelle, Charlotte Bouckaert, et al.
Pageof 7